Anavex Life Sciences CorpNASDAQ:AVXL
- LAST PRICE3.6900
- TODAY'S CHANGE (%)0.0400 (1.0959%)
- Bid / Lots3.6100/ 1
- Ask / Lots3.7800/ 15
- Open / Previous Close3.6600 / 3.6500
- Day Range
- 52 Week Range
- Volume1,434,796
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AVXL |
|---|---|---|
| 09:32 ET | 45947 | 3.64 |
| 09:34 ET | 14744 | 3.63 |
| 09:36 ET | 14082 | 3.64 |
| 09:38 ET | 4920 | 3.65 |
| 09:39 ET | 20100 | 3.66 |
| 09:41 ET | 2215 | 3.65 |
| 09:43 ET | 3089 | 3.665 |
| 09:45 ET | 2214 | 3.68 |
| 09:48 ET | 12787 | 3.645 |
| 09:50 ET | 726 | 3.66 |
| 09:52 ET | 2370 | 3.66 |
| 09:54 ET | 2287 | 3.655 |
| 09:56 ET | 1100 | 3.65 |
| 09:57 ET | 11850 | 3.665 |
| 09:59 ET | 800 | 3.67 |
| 10:01 ET | 2800 | 3.655 |
| 10:03 ET | 800 | 3.65 |
| 10:06 ET | 4432 | 3.64 |
| 10:08 ET | 907 | 3.65 |
| 10:10 ET | 1700 | 3.665 |
| 10:12 ET | 2600 | 3.645 |
| 10:14 ET | 1000 | 3.655 |
| 10:15 ET | 463 | 3.655 |
| 10:17 ET | 212 | 3.655 |
| 10:19 ET | 100 | 3.655 |
| 10:24 ET | 600 | 3.655 |
| 10:26 ET | 500 | 3.655 |
| 10:28 ET | 100 | 3.655 |
| 10:30 ET | 700 | 3.655 |
| 10:32 ET | 310 | 3.655 |
| 10:33 ET | 1800 | 3.64 |
| 10:35 ET | 100 | 3.64 |
| 10:39 ET | 1957 | 3.655 |
| 10:42 ET | 100 | 3.655 |
| 10:44 ET | 1569 | 3.665 |
| 10:46 ET | 621 | 3.67 |
| 10:48 ET | 5122 | 3.655 |
| 10:50 ET | 200 | 3.65 |
| 10:51 ET | 200 | 3.655 |
| 10:53 ET | 400 | 3.65 |
| 10:55 ET | 1700 | 3.65 |
| 10:57 ET | 200 | 3.655 |
| 11:00 ET | 6947 | 3.61 |
| 11:02 ET | 200 | 3.615 |
| 11:04 ET | 1308 | 3.61 |
| 11:08 ET | 4649 | 3.59 |
| 11:09 ET | 7475 | 3.595 |
| 11:11 ET | 4001 | 3.59 |
| 11:13 ET | 200 | 3.6 |
| 11:15 ET | 2600 | 3.59 |
| 11:18 ET | 500 | 3.595 |
| 11:20 ET | 4683 | 3.58 |
| 11:22 ET | 1600 | 3.59 |
| 11:24 ET | 1700 | 3.595 |
| 11:26 ET | 4000 | 3.6007 |
| 11:27 ET | 25042 | 3.555 |
| 11:29 ET | 2691 | 3.55 |
| 11:31 ET | 3654 | 3.555 |
| 11:33 ET | 1300 | 3.555 |
| 11:36 ET | 3348 | 3.57 |
| 11:38 ET | 3418 | 3.57 |
| 11:40 ET | 100 | 3.57 |
| 11:42 ET | 100 | 3.57 |
| 11:44 ET | 588 | 3.575 |
| 11:45 ET | 2000 | 3.5794 |
| 11:47 ET | 200 | 3.575 |
| 11:49 ET | 300 | 3.579 |
| 11:51 ET | 1000 | 3.575 |
| 11:54 ET | 1600 | 3.565 |
| 11:56 ET | 200 | 3.565 |
| 11:58 ET | 5778 | 3.5514 |
| 12:00 ET | 16899 | 3.535 |
| 12:02 ET | 4030 | 3.545 |
| 12:03 ET | 12000 | 3.575 |
| 12:05 ET | 1300 | 3.575 |
| 12:07 ET | 600 | 3.575 |
| 12:09 ET | 1030 | 3.575 |
| 12:12 ET | 3800 | 3.585 |
| 12:14 ET | 1029 | 3.58 |
| 12:16 ET | 3164 | 3.58 |
| 12:18 ET | 442 | 3.58 |
| 12:20 ET | 815 | 3.585 |
| 12:23 ET | 300 | 3.58 |
| 12:25 ET | 2704 | 3.595 |
| 12:27 ET | 641 | 3.595 |
| 12:30 ET | 627 | 3.595 |
| 12:32 ET | 3081 | 3.5965 |
| 12:34 ET | 1143 | 3.5901 |
| 12:36 ET | 291 | 3.595 |
| 12:38 ET | 5073 | 3.6 |
| 12:39 ET | 1802 | 3.595 |
| 12:41 ET | 200 | 3.595 |
| 12:43 ET | 600 | 3.59 |
| 12:45 ET | 10843 | 3.57 |
| 12:50 ET | 3100 | 3.5881 |
| 12:52 ET | 900 | 3.58 |
| 12:54 ET | 400 | 3.57 |
| 12:56 ET | 750 | 3.5889 |
| 12:59 ET | 200 | 3.585 |
| 01:01 ET | 700 | 3.575 |
| 01:03 ET | 1050 | 3.585 |
| 01:06 ET | 3500 | 3.58 |
| 01:08 ET | 1338 | 3.5704 |
| 01:10 ET | 800 | 3.575 |
| 01:12 ET | 250 | 3.575 |
| 01:14 ET | 900 | 3.57 |
| 01:15 ET | 450 | 3.5689 |
| 01:17 ET | 1450 | 3.56 |
| 01:19 ET | 100 | 3.565 |
| 01:21 ET | 100 | 3.565 |
| 01:24 ET | 200 | 3.565 |
| 01:26 ET | 400 | 3.57 |
| 01:28 ET | 200 | 3.565 |
| 01:30 ET | 300 | 3.565 |
| 01:32 ET | 4525 | 3.585 |
| 01:33 ET | 520 | 3.585 |
| 01:35 ET | 1105 | 3.595 |
| 01:37 ET | 421 | 3.595 |
| 01:39 ET | 1299 | 3.595 |
| 01:42 ET | 2332 | 3.585 |
| 01:44 ET | 400 | 3.575 |
| 01:46 ET | 519 | 3.585 |
| 01:48 ET | 200 | 3.58 |
| 01:50 ET | 400 | 3.585 |
| 01:51 ET | 200 | 3.585 |
| 01:53 ET | 591 | 3.58 |
| 01:55 ET | 1584 | 3.595 |
| 01:57 ET | 1600 | 3.59 |
| 02:00 ET | 300 | 3.585 |
| 02:02 ET | 2206 | 3.585 |
| 02:04 ET | 500 | 3.6 |
| 02:06 ET | 1600 | 3.61 |
| 02:08 ET | 1626 | 3.61 |
| 02:09 ET | 2500 | 3.625 |
| 02:11 ET | 1586 | 3.62 |
| 02:13 ET | 8867 | 3.635 |
| 02:15 ET | 300 | 3.63 |
| 02:20 ET | 1424 | 3.63 |
| 02:22 ET | 828 | 3.64 |
| 02:24 ET | 1700 | 3.645 |
| 02:26 ET | 540 | 3.64 |
| 02:27 ET | 4197 | 3.67 |
| 02:29 ET | 1200 | 3.68 |
| 02:31 ET | 10835 | 3.665 |
| 02:33 ET | 6311 | 3.665 |
| 02:36 ET | 7242 | 3.66 |
| 02:38 ET | 1277 | 3.67 |
| 02:40 ET | 9722 | 3.73 |
| 02:42 ET | 3180 | 3.74 |
| 02:44 ET | 3200 | 3.74 |
| 02:45 ET | 4130 | 3.75 |
| 02:47 ET | 2195 | 3.76 |
| 02:49 ET | 4240 | 3.76 |
| 02:51 ET | 1021 | 3.775 |
| 02:54 ET | 5738 | 3.78 |
| 02:56 ET | 1927 | 3.79 |
| 02:58 ET | 3593 | 3.79 |
| 03:00 ET | 5069 | 3.82 |
| 03:02 ET | 2450 | 3.83 |
| 03:03 ET | 8146 | 3.8 |
| 03:05 ET | 6055 | 3.825 |
| 03:07 ET | 1576 | 3.82 |
| 03:09 ET | 5746 | 3.85 |
| 03:12 ET | 2732 | 3.84 |
| 03:14 ET | 5724 | 3.845 |
| 03:16 ET | 6076 | 3.835 |
| 03:18 ET | 4803 | 3.8011 |
| 03:20 ET | 10915 | 3.8 |
| 03:21 ET | 9779 | 3.78 |
| 03:23 ET | 14404 | 3.79 |
| 03:25 ET | 9077 | 3.79 |
| 03:27 ET | 5168 | 3.805 |
| 03:30 ET | 8312 | 3.775 |
| 03:32 ET | 8953 | 3.755 |
| 03:34 ET | 4334 | 3.755 |
| 03:36 ET | 7344 | 3.745 |
| 03:38 ET | 4842 | 3.735 |
| 03:39 ET | 6330 | 3.72 |
| 03:41 ET | 8835 | 3.715 |
| 03:43 ET | 5116 | 3.705 |
| 03:45 ET | 4364 | 3.705 |
| 03:48 ET | 15668 | 3.705 |
| 03:50 ET | 12205 | 3.695 |
| 03:52 ET | 13292 | 3.685 |
| 03:54 ET | 5462 | 3.685 |
| 03:56 ET | 38269 | 3.695 |
| 03:57 ET | 18106 | 3.69 |
| 03:59 ET | 31414 | 3.69 |
Today
Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL, from 2 hours ago by Dow Jones
2 hours ago by Dow JonesGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Anavex Life Sciences Corp. (AVXL), from 3 hours ago by Dow Jones
3 hours ago by Dow JonesAnavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXL, from 5 hours ago by Dow Jones
5 hours ago by Dow JonesSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex, from 8 hours ago by Dow Jones
8 hours ago by Dow JonesAVXL DEADLINE ALERT: Bernstein Liebhard LLP Reminds Anavex Life Sciences Corporation Investors of Upcoming Deadline, from 8 hours ago by Dow Jones
8 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Anavex Life Sciences Corp | 299.7M | -6.9x | --- |
Black Diamond Therapeutics Inc | 292.6M | -3.1x | --- |
Fibrobiologics Inc | 308.5M | -8.7x | --- |
Atea Pharmaceuticals Inc | 311.4M | -2.4x | --- |
Inovio Pharmaceuticals Inc | 290.0M | -1.9x | --- |
ESSA Pharma Inc | 284.5M | -11.3x | --- |
Company Information
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being developed to treat Alzheimer’s disease, Parkinson’s disease, and other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2 (MECP2). The Company’s product candidates include NAVEX 3-71, ANAVEX 1-41, and ANAVEX 1066. ANAVEX 3-71 is a central nervous system (CNS) penetrable potential disease modifying treatment for cognitive impairments. ANAVEX 1-41 is a sigma-1 agonist.
Contact Information
- Headquarters
- 630 5Th Avenue, 20Th FloorNEW YORK, NY, United States 10111
- Phone
- 800-689-3939
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Officer, Company Secretary
- Christopher Missling
- Principal Financial Officer, Treasurer
- Sandra Boenisch
- Lead Independent Director
- Claus van der Velden
- Independent Director
- Peter Donhauser
- Independent Director
- Jiong Ma
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $299.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 82.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.66 |
EPS | $-0.54 |
Book Value | $1.73 |
P/E Ratio | -6.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
